1. Home
  2. BCAB vs CVV Comparison

BCAB vs CVV Comparison

Compare BCAB & CVV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BCAB
  • CVV
  • Stock Information
  • Founded
  • BCAB 2007
  • CVV 1982
  • Country
  • BCAB United States
  • CVV United States
  • Employees
  • BCAB N/A
  • CVV N/A
  • Industry
  • BCAB Medicinal Chemicals and Botanical Products
  • CVV Industrial Machinery/Components
  • Sector
  • BCAB Health Care
  • CVV Technology
  • Exchange
  • BCAB Nasdaq
  • CVV Nasdaq
  • Market Cap
  • BCAB 22.3M
  • CVV 18.7M
  • IPO Year
  • BCAB 2020
  • CVV N/A
  • Fundamental
  • Price
  • BCAB $0.41
  • CVV $3.03
  • Analyst Decision
  • BCAB Buy
  • CVV
  • Analyst Count
  • BCAB 2
  • CVV 0
  • Target Price
  • BCAB $1.00
  • CVV N/A
  • AVG Volume (30 Days)
  • BCAB 421.1K
  • CVV 46.3K
  • Earning Date
  • BCAB 05-06-2025
  • CVV 05-13-2025
  • Dividend Yield
  • BCAB N/A
  • CVV N/A
  • EPS Growth
  • BCAB N/A
  • CVV N/A
  • EPS
  • BCAB N/A
  • CVV N/A
  • Revenue
  • BCAB $11,000,000.00
  • CVV $30,270,000.00
  • Revenue This Year
  • BCAB N/A
  • CVV N/A
  • Revenue Next Year
  • BCAB N/A
  • CVV N/A
  • P/E Ratio
  • BCAB N/A
  • CVV N/A
  • Revenue Growth
  • BCAB N/A
  • CVV 48.85
  • 52 Week Low
  • BCAB $0.24
  • CVV $2.46
  • 52 Week High
  • BCAB $2.53
  • CVV $4.80
  • Technical
  • Relative Strength Index (RSI)
  • BCAB 50.31
  • CVV 54.23
  • Support Level
  • BCAB $0.37
  • CVV $2.46
  • Resistance Level
  • BCAB $0.42
  • CVV $3.36
  • Average True Range (ATR)
  • BCAB 0.04
  • CVV 0.19
  • MACD
  • BCAB -0.01
  • CVV 0.05
  • Stochastic Oscillator
  • BCAB 35.88
  • CVV 62.78

About BCAB BioAtla Inc.

BioAtla Inc is a clinical-stage biopharmaceutical company. The company is engaged in the development of a novel class of specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its pipeline products comprise mecbotamab vedotin (BA3011), ozuriftamab vedotin (BA3021), and evalstotug (BA3071), and its Phase 1 clinical trial of BA3182 (CAB-EpCAM x CAB-CD3) and Bispecific antibody programs.

About CVV CVD Equipment Corporation

CVD Equipment Corp is engaged in the manufacturing of chemical vapor deposition equipment, customized gas control systems, the manufacturing of process equipment suitable for the synthesis of a variety of one-dimensional nanostructures and nanomaterials and a line of furnaces, all of which are used to produce semiconductors and other electronic components. The company operates through the segments of CVD Equipment, CVD materials, and Stainless Design Concepts, MesoScribe. It generates maximum revenue from the CVD Equipment segment. The CVD Equipment segment manufactures and sells chemical vapor deposition, physical vapor transport, and similar equipment. Company operates in USA, North America, Europe, Middle East and Africa, and Asia-Pacific.

Share on Social Networks: